🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to explore the effectiveness of liraglutide combin...
Status
Completed
Location
The Third Affiliated Hospital of Sun Yat-sen University
Start Date
2014-08
Trial ID
NCT02147925
This study was the extension of the LANTU\_C\_02761 study named EASIE and i...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-06
Trial ID
NCT00851903
Treatments Being Tested
The purpose of this study is to investigate the safety and efficacy of long...
Status
Completed
Location
Multiple Locations
Start Date
2010-07
Trial ID
NCT02024971
Treatments Being Tested
This trial is conducted in Asia. The aim of this trial is to compare effica...
Status
Terminated
Location
Novo Nordisk Investigational Site
Start Date
2011-11
Trial ID
NCT01486966
Treatments Being Tested
The primary objective is to demonstrate the non-inferiority at six months o...
Status
Completed
Location
Investigational Site Number 204
Start Date
2009-07
Trial ID
NCT00965549
Treatments Being Tested
The purpose of this study is to compare the efficacy of Amaryl®M 1/500 mg t...
Status
Completed
Location
HeeYoung Lee
Start Date
2009-05
Trial ID
NCT00913367
Primary Objective: To compare the insulin glargine/lixisenatide fixed rati...
Status
Completed
Location
Investigational Site Number 840027
Start Date
2014-02
Trial ID
NCT02058147
The purpose of this study is to assess the safety and efficacy of omariglip...
Status
Completed
Location
Multiple Locations
Start Date
2013-01-11
Trial ID
NCT01755156
The primary objective was to demonstrate the superiority of insulin glargin...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-11
Trial ID
NCT00751114
Treatments Being Tested
This trial is conducted in Europe, and North and South America. The aim of ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2010-10-29
Trial ID
NCT01232491
Treatments Being Tested